I. Courdier-Fruh - Concepedia

Concepedia

Author

I. Courdier-Fruh

Santhera Pharmaceuticals (Switzerland)

Also Known As

I. Courdier-Fruh, Isabelle Courdier-Fruh, Isabelle Courdier-Früh, Isabelle Courdier‐Fruh

21

Publications

1.1K

Citations

12

H-Index

17

Concepts

All Affiliations

Santhera Pharmaceuticals (Switzerland)Spital Limmattal Noorik Biopharmaceuticals (Switzerland)

IC

About

I. Courdier-Fruh is an author at Santhera Pharmaceuticals (Switzerland) specializing in medicine, physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	649
2	Allergy	1	1	89
3	Biochemistry	1	1	37
4	Cellular Physiology	1	1	47
5	Immunology	1	1	129

I. Courdier-Fruh

×

12

Publications

1.1K

Citations

12

H-Index

	Year	Citations
Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse Alexandre Briguet, I. Courdier-Fruh, Mark Foster, Neuromuscular Disorders MechanobiologyMuscle FunctionSkeletal MuscleMedicinePhysiology	2004	419
A Multidisciplinary Evaluation of the Effectiveness of Cyclosporine A in Dystrophic Mdx Mice Annamaria De Luca, Beatrice Nico, Antonella Liantonio, American Journal Of Pathology Multidisciplinary EvaluationTranslational MedicineMedicinePhysiologyImmunology	2005	129
Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance Gunnar Buyse, Gerry Van der Mieren, Michael A. Erb, European Heart Journal	2008	99
Reduced expression of nicotinic AChRs in myotubes from spinal muscular atrophy I patients Anne‐Sophie Arnold, Mor Gueye, Séverine Guettier‐Sigrist, Laboratory Investigation AllergySkeletal MusclePhysiologySpinal Muscular AtrophyNeuromusculoskeletal Disorder	2004	89
Omigapil Ameliorates the Pathology of Muscle Dystrophy Caused by Laminin-α2 Deficiency Michael A. Erb, Sarina Meinen, Patrizia Barzaghi, Journal of Pharmacology and Experimental Therapeutics	2009	86
The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia Robert Dallmann, Philipp Weyermann, Corinne Anklin, Journal of Cachexia Sarcopenia and Muscle	2011	55
Effect of calpain and proteasome inhibition on Ca <sup>2+</sup> ‐dependent proteolysis and muscle histopathology in the <i>mdx</i> mouse Alexandre Briguet, Michael A. Erb, I. Courdier-Fruh, The FASEB Journal	2008	53
Orally Available Selective Melanocortin-4 Receptor Antagonists Stimulate Food Intake and Reduce Cancer-Induced Cachexia in Mice Philipp Weyermann, Robert Dallmann, Josef P. Magyar, PLoS ONE	2009	51
Glucocorticoid-mediated regulation of utrophin levels in human muscle fibers I. Courdier-Fruh, Lee Barman, Alexandre Briguet, Neuromuscular Disorders Muscle FunctionMolecular PhysiologySkeletal MusclePhysiologyUtrophin Levels	2002	47
Novel cell-penetrating α-keto-amide calpain inhibitors as potential treatment for muscular dystrophy Cyrille Lescop, Holger Herzner, H. Siendt, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryMedicinePharmacologyDrug Discovery	2005	37

Page 1